Publications
-
Prevention of HIV-1 infection with early antiretroviral therapy
Citation: Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR; HPTN 052 Study Team. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011 Aug 11;365(6):493-505. doi: 10.1056/NEJMoa1105243. Epub 2011 Jul 18. PMID: 21767103 PMCID: PMC3200068.
Date: 03/11/2015
Twelve-month follow-up of Six Week Extended Dose Nevirapine randomized controlled trials:
Citation: Omer SB, Six Week Extended Dose Nevirapine (SWEN) Study Team. Twelve-month follow-up of Six Week Extended Dose Nevirapine randomized controlled trials: differential impact of extended-dose nevirapine on mother-to-child transmission and infant death by maternal CD4 cell count. AIDS. 2011 Mar 27;25(6):767-76. doi: 10.1097/QAD.0b013e328344c12a. PMID: 21330912.
Date: 03/11/2015
Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency
Citation: Gupta A, Bhosale R, Kinikar A, Gupte N, Bharadwaj R, Kagal A, Joshi S, Khandekar M, Karmarkar A, Kulkarni V, Sastry J, Mave V, Suryavanshi N, Thakar M, Kulkarni S, Tripathy S, Sambarey P, Patil S, Paranjape R, Bollinger RC, Jamkar A; Six Week Extended-Dose Nevirapine (SWEN) India Study Team. Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency virus. J Infect Dis. 2011 Feb 1;203(3):358-63. doi: 10.1093/infdis/jiq064. PMID: 21208928. PMCID: PMC3071111.
Date: 03/11/2015
Tuberculosis in women and children
Citation: Marais BJ, Gupta A, Starke JR, El Sony A. Tuberculosis in women and children. Lancet. 2010 Jun 12;375(9731):2057-9. doi: 10.1016/S0140-6736(10)60579-X. Epub 2010 May 18. PMID: 20488522.
Date: 03/11/2015
Syphilis in HIV-infected mothers and infants: results from the NICHD/HPTN 040 study
Citation: Yeganeh N, Watts HD, Camarca M, Soares G, Joao E, Pilotto JH, Gray G, Theron G, Santos B, Fonseca R, Kreitchmann R, Pinto J, Mussi-Pinhata M, Ceriotto M, Machado DM, Grinzstejn B, Veloso VG, Morgado MG, Bryson Y, Mofenson LM, Nielsen-Saines K; NICHD HPTN 040P1043 Study Team. Syphilis in HIV-infected mothers and infants: results from the NICHD/HPTN 040 study. Pediatr Infect Dis J. 2015 Mar;34(3):e52-7. doi: 10.1097/INF.0000000000000578. Erratum in: Pediatr Infect Dis J. 2015 Sep;34(9):1038. PMID: 25742089; PMCID: PMC4352722
Date: 03/01/2015
Differential skeletal impact of tenofovir disoproxil fumarate in young versus old HIV-infected adult
Citation: Grant, PM, Kitch D, McComsey GA, Tierney C, Ha B, Brown TT. Differential skeletal impact of tenofovir disoproxil fumarate in young versus old HIV-infected adults. HIV Clin Trials. 2015 Mar-Apr;16(2):66-71. PMID: 25872972. PMCID: PMC4467768.
Date: 03/01/2015
C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide
Citation: Tenforde MW, Gupte N, Dowdy DW, Asmuth DM, Balagopal A, Pollard RB, Sugandhavesa P, Lama JR, Pillay S, Cardoso SW, Pawar J, Santos B, Riviere C, Mwelase N, Kanyama C, Kumwenda J, Hakim JG, Kumarasamy N, Bollinger R, Semba RD, Campbell TB, Gupta A; ACTG PEARLS and NWCS 319 Study Group. C-Reactive Protein (CRP), Interferon Gamma-Inducible Protein 10 (IP-10), and Lipopolysaccharide (LPS Lipopolysaccharide (LPS) Are Associated with Risk of Tuberculosis after Initiation of Antiretroviral Therapy in Resource-Limited Settings. PLoS One. 2015 Feb 26;10(2):e0117424. doi: 10.1371/journal.pone.0117424. PMID: 25719208. PMCID: PMC4342263.
Date: 02/26/2015
Viremic relapse following HIV-1 remission in a perinatally infected child
Citation: Luzuriaga K, Gay H, Ziemniak C, Sanborn K, Somasundaran, Rainwater-Lovett K, Mellors J, Rosenbloom D. I.S, Persaud D. Viremic relapse following HIV-1 remission in a perinatally infected child. N Engl J Med. 2015 Feb 19;372(8):786-8. PMID 25693029; PMCID PMC4440331
Date: 02/19/2015
Prevalence and correlates of knowledge of male partner HIV testing and serostatus among
Citation: Jennings L, Rompalo AM, Wang J, Hughes J, Adimora AA, Hodder S, Soto-Torres LE, Frew PM, Haley DF; HIV Prevention Trials Network (HPTN 064) Women’s HIV SeroIncidence Study (ISIS). Prevalence and correlates of knowledge of male partner HIV testing and serostatus among African-American women living in high poverty, high HIV prevalence communities (HPTN 064). AIDS Behav. 2015 Feb;19(2):291-301. doi: 10.1007/s10461-014-0884-y.
Date: 02/15/2015
Long-term safety and efficacy of atazanavir-based therapy in HIV-infected infants, children and
Citation: Rutstein RM, Samson P, Fenton T, Fletcher CV, Kiser JJ, Mofenson LM, Smith E, Graham B, Mathew M, Aldrovani G; PACTG 1020A Study Team. Long-term safety and efficacy of atazanavir-based therapy in HIV-infected infants, children and adolescents: the Pediatric AIDS Clinical Trials Group Protocol 1020A. Pediatr Infect Dis J. 2015 Feb;34(2):162-7. doi: 10.1097/INF.0000000000000538. PMID: 25232777; PMCID: PMC4355059
Date: 02/01/2015
- ‹ First < 18 19 20 21 22 > Last ›